About PowerVision Lens
PowerVision Lens is a Healthcare company based in Belmont (United States) founded in 2002, and was acquired by Alcon in March 2019. Implantable intraocular lenses with fluid accommodation are developed. PowerVision Lens has raised $109.06 million across 6 funding rounds from investors including Medtronic, Alcon and J P Morgan. The company has 59 employees. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is POWERVISION, INC. Its competitors include RxSight, STAAR Surgical and Atia Vision; 2 of its 3 listed competitors have raised funding.
Company details
PowerVision was founded in 2002 in Belmont, United States, as a medical device company focused on ophthalmology. Implantable intraocular lenses, including the FluidVision model, are developed to accommodate natural eye muscle movements through contained fluid. Operations center on advancing lens technology for vision correction, though FDA approval remains pending. The domain powervisionlens.com is maintained for company information.
- Headquarters Belmont, United States
- Employees 59
- Stage Acquired
- SectorsHealthcare
- Website powervisionlens.com
- Acquired by Alcon (Mar 2019)
- Legal Name Powervision, Inc.
Funding Insights of PowerVision Lens
PowerVision Lens has successfully raised a total of $109.06M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $45.06 million completed in July 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $109.06M
- Total Rounds 6
- Last Round Series D — $45.06M
- First Round $4.43M
(Jun 2005)
- Investors Count 10
All 6 funding rounds of PowerVision Lens with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2016 | $45.06M | Series D | – | Venrock, Medtronic | – |
| Dec 2011 | $12.5M | Series C | – | Johnson & Johnson Innovation – JJDC | |
| Apr 2011 | $24.72M | Series C | – | Medtronic, Venrock | |
| Feb 2008 | $20.35M | Series B | – | – | |
| Mar 2006 | $2M | Series A | – | – | – |
| Jun 2005 | $4.43M | Series A | – | – | – |
11 investors in total: 11 institutional.
Investors in PowerVision Lens
PowerVision Lens has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Alcon and J P Morgan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on tech sectors | venrock.com | Palo Alto, United States | ||
VC firm making investment in early stage startups in the US | atvcapital.com | Menlo Park, United States | ||
Secondary private equity and co-investments are managed diversely. | 1994 | lexingtonpartners.com | New York, United States | |
Healthcare sector private equity investments are managed by the firm. | 1991 | frazierhealthcare.com | Seattle, United States | |
PE firm investing in the US | aislingcapital.com | New York, United States | ||
Venture capital firm focused on aerospace, biopharma, consumer, and multiple sectors | correlationvc.com | San Francisco, United States | ||
Venture capital firm backed by Johnson & Johnson | jnjinnovation.com/jjdc | Cambridge, United States | ||
Early & later stage venture capital firm investing in the US | panoramacapital.com | Campbell, United States | ||
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | medtronic.com | Minneapolis, United States | |
Comprehensive financial services are provided to corporations and individuals. | 1799 | jpmorgan.com | New York, United States |
Investor details for PowerVision Lens
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of PowerVision Lens
4 dated milestones of PowerVision Lens across 17 years, from founding to its latest funding, stage changes and deals.
- Founded PowerVision Lens is founded.
- Funding First funding round of $4.4M.
- Funding Latest funding round, Series D, of $45.1M.
- Exit Acquired by Alcon.
Competitors of PowerVision Lens
PowerVision Lens has 3 listed competitors in our database, 2 of them funded. They include RxSight, STAAR Surgical and Atia Vision.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rxsight.com | 1997 | Aliso Viejo, United States | $198.73M | 263 | Adjustable intraocular lens technology is developed using UV-sensitive macromers. | |
| staar.com | 1982 | Monrovia, United States | 1,115 | Manufacturer of implantable lenses for the eye with companion delivery systems | ||
| atiavision.com | 2012 | Campbell, United States | $67M | A presbyopia-correcting intraocular lens is developed for cataract patients. |
Detailed competitors of PowerVision Lens
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Ophthalmology
3 companies that operate in the same segment as PowerVision Lens (Ophthalmology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PowerVision Lens
PowerVision Lens was founded in 2002 and raised its 1st funding round 3 years after it was founded.
PowerVision Lens is headquartered in Belmont, United States. It is registered at Belmont, California, United States.
PowerVision Lens is a funded company, having raised a total of $109.06M across 6 funding rounds to date. The company's 1st funding round was a Series A of $4.43M, raised on Jun 2005.
PowerVision Lens has 59 employees.
PowerVision was founded in 2002 in Belmont, United States, as a medical device company focused on ophthalmology. Implantable intraocular lenses, including the FluidVision model, are developed to accommodate natural eye muscle movements through contained fluid. Operations center on advancing lens technology for vision correction, though FDA approval remains pending. The domain powervisionlens.com is maintained for company information.
PowerVision Lens's top competitors include RxSight, Atia Vision and STAAR Surgical.
PowerVision Lens has 11 investors. Key investors include Medtronic, Alcon, J P Morgan, Lexington Partners, and Frazier Healthcare Partners.
PowerVision Lens operates through Powervision, Inc..
Yes. PowerVision Lens was acquired by Alcon in March 2019.